Trials / Completed
CompletedNCT00783731
Low Dose of Midazolam is Superior to Conventional Dose for Rapid Sequence Intubation in Emergency Department (ED)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Midazolam has been used in rapid sequence intubation for a long time, and the recommended dose is 0.1mg/kg. In some studies, however, the reduced dose has been used with the concern of hemodynamic instability. We would like to investigate that the low dose midazolam could be used rather than the standard recommended dose, and also compare it to the etomidate, recently used sedatives, with respect to the side effects and the easy performance of intubation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Low dose midazolam |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-10-01
- Completion
- 2011-01-01
- First posted
- 2008-11-03
- Last updated
- 2011-07-26
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00783731. Inclusion in this directory is not an endorsement.